Pharmacologic "Protection" to Reduce Strokes After TAVR: Current Evidence and Recommendations

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Grant Support/Research Contract (Institutional) - Boston Scientific Corporation; AstraZenca; Abbott Vascular; Bayer AG; Daiichi-Sankyo/Elil Lilly and Company; Medtronic